Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedstar Health Research Institute

About this trial

The goal of this observational qualitative study is to learn about the experiences and perspectives of patients with neurogenic lower urinary tract dysfunction (NLUTD) and their caregivers regarding different types of intravesical instillations used for urinary health. The study aims to understand the perceived benefits, challenges, and opportunities related to Lactobacillus-only, gentamicin-only, and combined gentamicin-Lactobacillus instillations. The main question this study seeks to answer is:

1\. Determine patient and caregivers' preferences, and overall experiences regarding intravesical therapeutics for urinary symptoms and UTI

Researchers will compare responses from four groups: participants who have used Lactobacillus-only instillations, gentamicin-only instillations, combined gentamicin-Lactobacillus instillations, and caregivers who have experience supporting instillations.

Participants will take part in a one-hour semi-structured interview and may be contacted for brief follow-up discussions to clarify findings. Interviews will be audio-recorded, transcribed, and analyzed using qualitative data software to identify themes related to treatment preferences and acceptability.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18+

Diagnosis of NLUTD

Chronic catheter usage (minimum 6 months), either intermittent catheterization or indwelling catheter

Community-dwelling

Disqualifiers

Psychiatric or psychologic conditions impacting ability to consent

Trial population

Participants will be recruited from populations that have used Lactobacillus, gentamicin, or combination of the two.

Trial design

Design model

Other

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Advancing intravesical instillation for urinary health

Qualitative interviews will be coded, and themes how to advance intravesical instillation for urinary health will emerge.

Time frame
12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Medstar Health Research Institute

Lead sponsor

Congressionally Directed Medical Research Programs

Collaborator